Paterson, Ian;
White, James;
Butler, Craig;
Connelly, Kim;
Guerra, Peter;
Hill, Michael;
Sarak, Bradley;
Sterns, Laurence;
Verma, Atul;
Wan, Douglas;
Crean, Andrew;
Grosse-Wortmann, Lars;
Hanneman, Kate;
Leipsic, Jonathon;
Manlucu, Jaimie;
Villemaire, Christine;
Wald, Rachel;
Windram, Jonathan.
Magnetic resonance imaging (MRI) is often considered the gold-standard test for characterizing cardiac as well as noncardiac structure and function. However, many patients with cardiac implantable electronic devices (CIEDs) and/or severe renal dysfunction are unable to undergo this test because of safety...
Andrade, J. G;
Aguilar, M;
Atzema, C;
Bell, A;
Cairns, J. A;
Cheung, C. C;
Cox, JL;
Dorian, P;
Gladstone, D. J;
Healey, J. S;
Khairy, P;
Leblanc, K;
McMurtry, M. S;
Mitchell, L. B;
Nair, G. M;
Nattel, S;
Parkash, R;
Pilote, L;
Sandhu, R. K;
Sarrazin, J. F;
Sharma, M;
Skanes, A. C;
Talajic, M;
Tsang, T. S. M;
Verma, A;
Verma, S;
Whitlock, R;
Wyse, D. G;
Macle, L.
The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was developed to aid clinicians in the management of these complex patients, as well as to provide direction to policy makers and health care systems regarding related issues. The most recent comprehensive CCS AF guidel...
Fibrilación Atrial/diagnóstico,
Fibrilación Atrial/terapia,
Fibrilación Atrial/epidemiología,
Fibrilación Atrial/clasificación,
Factores de Riesgo,
Accidente Cerebrovascular/prevención & control,
Fibrilación Atrial/fisiopatología,
Factores Sexuales,
Grupos de Riesgo,
Algoritmos,
Vías Clínicas
Dent, S;
Brezden-Masley, C;
Clarke, B;
Davis, MK;
Jassal, DS;
Johnson, C;
Lemieux, J;
Paterson, I;
Sebag, IA;
Simmons, C;
Sulpher, J;
Thain, K;
Thavendiranathan, P;
Wentzell, JR;
Wurtele, N;
Côté, MA;
Fine, NM;
Haddad, H;
Hayley, BD;
Hopkins, S;
Joy, AA;
Rayson, D;
Stadnick, E;
Straatman, L;
Virani, SA.
Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
Antineoplásicos,
Biomarcadores,
Cardiotónicos,
Cardiotoxinas,
Troponina T,
Péptido Natriurético Encefálico,
Proteína C-Reactiva,
Antineoplásicos/efectos adversos,
Arritmias Cardíacas,
Cardiotoxicidad,
Trombosis Coronaria,
Diagnóstico Precoz,
Ecocardiografía Tridimensional,
Hipertensión/terapia,
Imagen por Resonancia Cinemagnética,
Isquemia Miocárdica,
Neoplasias/terapia,
Prevención Primaria,
Radioterapia,
Factores de Riesgo,
Disfunción Ventricular Izquierda,
Cardiotoxicidad/diagnóstico,
Cardiotoxinas/efectos adversos,
Radioterapia/efectos adversos
Appoo, JJ;
Bozinovski, J;
Chu, MW;
El-Hamamsy, I;
Forbes, TL;
Moon, M;
Ouzounian, M;
Peterson, MD;
Tittley, J;
Boodhwani, M.
In 2014, the Canadian Cardiovascular Society (CCS) published a position statement on the management of thoracic aortic disease addressing size thresholds for surgery, imaging modalities, medical therapy, and genetics. It did not address issues related to surgical intervention. This joint Position Stateme...
